Effects of Simvastatin on Inflammatory Response and Biological Behaviour of Adamantinomatous Craniopharyngioma
Neuroendocrinology · 2024
DOI: 10.1159/000539821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroendocrinology, 2024. Verfasst von Weizhao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China, 1012030534@qq.com. Hauptthemen laut MEDLINE: Craniopharyngioma, Pituitary Neoplasms, Simvastatin, Apoptosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Introduction
The aim of this study was to investigate the autoinflammatory effect and biological behaviour of simvastatin (SIM) on adamantinomatous craniopharyngioma (ACP) cells.
Methods
Craniopharyngiomas imaging, intraoperative observations, and tumour histopathology were employed to investigate the correlation between esters and craniopharyngiomas. Filipin III fluorescent probe verified the validity of SIM on the alternations of synthesized cholesterol in craniopharyngioma cells. The cell counting kit-8 (CCK8) assay detected the impacts of SIM on cell proliferation and determined the IC50 value of tumour cells. Reverse transcription polymerase chain reaction (RT-PCR) measured the expression of inflammatory factors. Flow cytometry technique detected the cell cycle and apoptosis, and cell scratch assay judged the cell migration. Meanwhile, Western blot was adopted to determine the expression of proteins related to inflammation, proliferation, and apoptosis signalling pathways.
Results
In the ACP tumour parenchyma, many cholesterol crystalline clefts were observed, and the deposition of esters was closely associated with craniopharyngioma inflammation. After SIM intervention, a reduction in cholesterol synthesis within ACP was noted. RT-PCR analysis revealed SIM inhibited the transcription of inflammatory factors in ACP cells. Western blot analysis demonstrated SIM inhibited nuclear factor-kappa B p65 activation expression while promoted the expressions of Cl-caspase-3 and P38 MAPK. CCK8 assay indicated a decrease in ACP cell activity upon SIM treatment. Scratch assay signified that SIM hindered ACP cell migration. Flow cytometry results suggested that the drug promoted ACP cell apoptosis.
Conclusion
SIM suppressed the inflammatory response to craniopharyngiomas by inhibiting craniopharyngioma cholesterol synthesis, inhibited proliferation of ACP cells, and promoted their apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China, 1012030534@qq.com.
- Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China.
Zitieren
APA
Li, W., Zhang, Y., Zhuang, Y., Chen, R., Xiong, Z., Li, K., Liu, F., Xu, H., Li, D., & Peng, J. (2024). Effects of Simvastatin on Inflammatory Response and Biological Behaviour of Adamantinomatous Craniopharyngioma. Neuroendocrinology. https://doi.org/10.1159/000539821
Vancouver
Li W, Zhang Y, Zhuang Y, Chen R, Xiong Z, Li K, et al. Effects of Simvastatin on Inflammatory Response and Biological Behaviour of Adamantinomatous Craniopharyngioma. Neuroendocrinology. 2024. doi:10.1159/000539821
BibTeX
@article{Li2024,
author = {Li, Weizhao and Zhang, Yunxiao and Zhuang, Yishan and Chen, Rongjun and Xiong, Zhiwei and Li, Kai and Liu, Fang and Xu, Haiyan and Li, Danling and Peng, Junxiang},
title = {Effects of Simvastatin on Inflammatory Response and Biological Behaviour of Adamantinomatous Craniopharyngioma},
journal = {Neuroendocrinology},
year = {2024},
doi = {10.1159/000539821}
}
EUVIMED